Kuick Research Report Gives Detailed Insight On Ongoing Rare Disease Drug Market And Highlights Ongoing Clinical TrialsDelhi, ...

Kuick Research Report Gives Detailed Insight On More Than 1400 FDA Orphan Designated Drugs And Highlights More Than USD 190 ...

THE001, a thermosensitive doxorubicin liposome for soft tissue sarcomas, received FDA orphan drug designation, offering ...

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of radiation treatments in preclinical models, according to a study by UT ...

This milestone strengthens the company's FDA Orphan Drug Application and positions Exousia Pro to become a leader in innovative cancer treatments. Nearly 90% of glioblastoma preclinical studies rely ...

To ensure timely access to life-saving orphan drugs for patients, the government has exempted mandatory sampling and testing at port offices. The drug regulator will now release consignments based on ...

Credit: luchschenF/Shutterstock. The European Commission (EC) has granted orphan drug designation to Dyne Therapeutics’ DYNE-251 for treating Duchenne muscular dystrophy (DMD). This designation is ...

Investing.com -- Shares of Dyne Therapeutics (NASDAQ:DYN) climbed 3.9% following the announcement that the European Commission has granted orphan drug designation to the company’s lead product ...

Investing.com -- Shares of Dyne Therapeutics (NASDAQ:DYN) climbed 3.9% following the announcement that the European Commission has granted orphan drug designation to the company’s lead product ...